TIAA Report Asks Choice

WASHINGTON—A draft report on the nation’s largest teachers’ pension system recommends a variety of new investment choices for its policyholders—but still may not silence its swelling chorus of critics. The report by a special trustee committee of the Teachers Insurance and Annuity Association-College Retirement Equities Fund (TIAA-CREF) calls for adding six pension funds to the $63 billion system. More than 1 million policyholders have joined the system in plans offere


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—A draft report on the nation’s largest teachers’ pension system recommends a variety of new investment choices for its policyholders—but still may not silence its swelling chorus of critics.

The report by a special trustee committee of the Teachers Insurance and Annuity Association-College Retirement Equities Fund (TIAA-CREF) calls for adding six pension funds to the $63 billion system. More than 1 million policyholders have joined the system in plans offered by some 3,800 colleges, universities, independent schools and nonprofit research institutions.

Current policyholders have been limited to the TIAA fixed annuity fund and the CREF equity fund, although a money market fund will soon be added. The small number of choices and the lack of transferability between funds have drawn much criticism. The new options recommended in the report include adding a second fixed annuity fund to TIAA and five variable annuity funds—including a bond fund and several equities funds—to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo